Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus
Authors:
- R J van der SchaafRSR J van der Schaaf
- J P S HenriquesJHJ P S Henriques
- J J WiersmaJWJ J Wiersma
- K T KochKKK T Koch
- J BaanJBJ Baan
- K J J MulderKMK J J Mulder
- J D DurrerJDJ D Durrer
- J G P TijssenJTJ G P Tijssen
- J J PiekJPJ J Piek
- R J de WinterRWR J de Winter
Open Access
Abstract
We therefore studied one year mortality among patients with and without DM in a large cohort of patients with acute STEMI treated with primary PCI. Furthermore, we studied the impact of preadmission treatment for DM, either oral medication or with insulin.Keywords
This publication has 5 references indexed in Scilit:
- Long-term, cause-specific mortality after myocardial infarction in diabetesEuropean Heart Journal, 2004
- Type 2 Diabetes and Intravenous Thrombolysis Outcome in the Setting of ST Elevation Myocardial InfarctionDiabetes Care, 2004
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysisHeart, 2002
- Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.JACC, 1997